Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines

被引：7

作者：

Hur, Jin-Wuk ^{[1
]}

Choe, Jung-Yoon ^{[2
]}

Kim, Dong-Wook ^{[3
]}

Kim, Hyun Ah ^{[4
]}

Kim, Sang-Hyon ^{[5
]}

Kim, Wan-Uk ^{[6
]}

Kim, Yun Sung ^{[7
]}

Lee, Hye-Soon ^{[8
]}

Lee, Sang-Heon ^{[9
]}

Park, Sung-Hwan ^{[6
]}

Park, Won ^{[10
]}

Park, Yong-Beom ^{[11
]}

Suh, Chang-Hee ^{[12
]}

Shim, Seung-Cheol ^{[13
]}

Song, Yeong-Wook ^{[14
]}

Yoon, Bo Young ^{[15
]}

Yu, Dae Young ^{[16
]}

Yoo, Dae Hyun ^{[17
]}

机构：

[1] Eulji Gen Hosp, Seoul, South Korea

[2] Daegu Catholic Univ, Med Ctr, Daegu, South Korea

[3] Inje Univ, Busan Paik Hosp, Busan, South Korea

[4] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea

[5] Keimyung Univ, Dongsan Hosp, Daegu, South Korea

[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[7] Chosun Univ Hosp, Gwangju, South Korea

[8] Hanyang Univ, Guri Hosp, Guri, South Korea

[9] Konkuk Univ, Med Ctr, Seoul, South Korea

[10] Inha Univ Hosp, Inchon, South Korea

[11] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea

[12] Ajou Univ Hosp, Suwon, South Korea

[13] Chungnam Natl Univ Hosp, Taejon, South Korea

[14] Seoul Natl Univ Hosp, Seoul 110744, South Korea

[15] Inje Univ, Ilsan Paik Hosp, Ilsan, South Korea

[16] Janssen Korea, Med Affairs, Seoul, South Korea

[17] Hanyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul 133791, South Korea

来源：

RHEUMATOLOGY INTERNATIONAL | 2015年 / 35卷 / 11期

关键词：

Rheumatoid arthritis; Anti-TNF alpha agents; Treatment; Reimbursement guidelines; RECOMMENDATIONS; MANAGEMENT; UPDATE; AGENTS;

D O I：

10.1007/s00296-015-3353-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this study was to compare anti-tumor necrosis factor-alpha (TNF alpha) treatment status in rheumatoid arthritis (RA) patients with the Korean National Health Insurance (KNHI) reimbursement eligibility criteria and with American College of Rheumatology (ACR) recommendations, Japan College of Rheumatology (JCR) guidelines and British Society for Rheumatology (BSR) guidelines. Between December 2011 and August 2012, outpatients from 17 South Korean general hospitals diagnosed with RA according to the 1987 ACR criteria were enrolled into a noninterventional, cross-sectional, observational study. Of 1700 patients (1414 female (83.2 %), mean age of 56.6 +/- A 12.0, mean disease duration 97.9 +/- A 91.8 months), 306 (18.0 %) had used anti-TNF alpha agents, and 224 (13.2 %) were currently using an anti-TNF alpha agent. Of 1394 anti-TNF alpha-naive patients, 32 (2.3 %) met KNHI reimbursement guidelines, 148 (10.6 %) met ACR recommendations, and 127 (9.1 %) and 126 (9.0 %) were considered eligible for anti-TNF alpha agents according to JCR and BSR guidelines, respectively. The main discrepancy was the higher active joint count required by the KNHI eligibility criteria. In the opinion of treating rheumatologists, the KNHI reimbursement criteria ineligibility accounted for 15.3 % (n = 213) of the reasons for not initiating anti-TNF alpha agents in anti-TNF alpha-naive group. The anti-TNF alpha user group showed significantly higher disease activity than the anti-TNF alpha-naive group based on DAS28 score. In comparison with the ACR recommendations and JCR and BSR guidelines, fewer patients met KNHI reimbursement eligibility criteria for anti-TNF alpha agents. The current amendment of the KNHI criteria based on DAS28 score will improve an access to biologic agents including anti-TNF alpha treatment for South Korean patients with active RA.

引用

页码：1817 / 1823

页数：7

共 15 条

[1] Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis [J].

Bodur, H. ;

Ataman, S. ;

Akbulut, L. ;

Evcik, D. ;

Kavuncu, V. ;

Kaya, T. ;

Guenaydin, R. ;

Kuran, B. ;

Kotevoglu, N. ;

Bal, A. ;

Aydog, E. ;

Altay, Z. ;

Ugurlu, H. ;

Kocabas, H. ;

Olmez, N. ;

Yazgan, P. ;

Gursoy, S. ;

Madenci, E. ;

Ozel, S. ;

Delialioglu, S. Ue. .

CLINICAL RHEUMATOLOGY, 2008, 27 (09) :1119-1125

[2] EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) [J].

Combe, B. ;

Landewe, R. ;

Lukas, C. ;

Bolosiu, H. D. ;

Breedveld, F. ;

Dougados, M. ;

Emery, P. ;

Ferraccioli, G. ;

Hazes, J. M. W. ;

Klareskog, L. ;

Machold, K. ;

Martin-Mola, E. ;

Nielsen, H. ;

Silman, A. ;

Smolen, J. ;

Yazici, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (01) :34-45

[3] Compliance With Biologic Therapies for Rheumatoid Arthritis: Do Patient Out-of-Pocket Payments Matter? [J].

Curkendall, S. ;

Patel, V. ;

Gleeson, M. ;

Campbell, R. S. ;

Zagari, M. ;

Dubois, R. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (10) :1519-1526

[4]

Fauci AnthonyS., 2012, Harrison's Principles of Internal Medicine

[5] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 [J].

Furst, D. E. ;

Breedveld, F. C. ;

Kalden, J. R. ;

Smolen, J. S. ;

Burmester, G. R. ;

Sieper, J. ;

Emery, P. ;

Keystone, E. C. ;

Schiff, M. H. ;

Mease, P. ;

van Riel, P. L. C. M. ;

Fleischmann, R. ;

Weisman, M. H. ;

Weinblatt, M. E. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 :2-22

[6] Belgian rheumatologists perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria [J].

Geens, Elke ;

Geusens, Piet ;

Vanhoof, Johan ;

Berghs, Hubert ;

Praet, Johan ;

Esselens, Greet ;

Lens, Simonne ;

Dufour, Jean-Pol ;

Vandenberghe, Marc ;

Van Mullem, Xavier ;

Westhovens, Rene ;

Verschueren, Patrick .

RHEUMATOLOGY, 2009, 48 (05) :546-550

[7]

Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI 10.1002/art.23364

[8] Rheumatoid arthritis [J].

Klareskog, Lars ;

Catrina, Anca Irinel ;

Paget, Stephen .

LANCET, 2009, 373 (9664) :659-672

[9]

Koike Ryuji, 2007, Mod Rheumatol, V17, P451

[10] Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001) [J].

Ledingham, J ;

Deighton, C .

RHEUMATOLOGY, 2005, 44 (02) :157-163

← 1 2 →